Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding AG    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société ROCHE HOLDING AG
03/27ROCHE : FDA accepts Roche's New Drug Application for Xofluza (baloxavir marboxil..
PU
03/27ROCHE : FDA Accepts Genentech's New Drug Application for Xofluza for the Treatme..
BU
03/25ROCHE : Invitation to Roche's First Quarter Sales 2020 Audio Webcast and Confere..
PU
03/24ABBVIE : Announces Positive Topline Results from Phase 3 Trial of VENCLEXTA in C..
AQ
03/24CHUGAI PHARMACEUTICAL : Genentech Announces FDA approval of Clinical Trial for C..
AQ
03/24ROCHE : Can-Fite - Piclidenoson is submitted for Compassionate Use Treatment for..
AQ
03/24Roche response to COVID-19 pandemic
GL
03/23Chugai Files Patent Infringement Lawsuit against Fresenius Kabi in the U.S
AQ
03/23GENENTECH : Announces FDA Approval of Clinical Trial for Actemra to Treat Hospit..
BU
03/23GENENTECH : Announces Venclexta Combination Improved Overall Survival in People ..
BU
03/23Roche announces Venclexta/Venclyxto combination improved overall survival in ..
GL
03/20CHUGAI PHARMACEUTICAL : Roche Announces the Initiation of a Clinical Study of Ch..
AQ
03/19GENENTECH : Initiates Phase III Clinical Trial of Actemra in Hospitalized Patien..
BU
03/19Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised..
GL
03/18CHUGAI PHARMACEUTICAL : Selected as 2019 Tokyo Sports Promotion Model Company
AQ
03/17Roche Annual General Meeting 2020
GL
03/16ROCHE ANNUAL GENERAL MEETING 2020 : Voting will take place by independent proxy...
GL
03/16CHUGAI PHARMACEUTICAL : Orgazanizes a Workshop on Multidisciplinary Team Care in..
AQ
03/14Roche Annual General Meeting 2020 to take place under special conditions set ..
GL
03/12Roche's cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emerge..
GL
03/12ROCHE : ANF foils a bid to smuggle addictive drugs abroad
AQ
03/12ROCHE : European Commission approves Venclyxto plus Gazyvaro for adults with pre..
AQ
03/11ROCHE : 70% Nigerians living with undiagnosed diabetes - Roche Diabetes Care
AQ
03/11Roche receives FDA approval for CINtec PLUS Cytology test to aid clinicians i..
GL
03/10Arix names Dr Roberto Iacone as Entrepreneur in Residence
AQ
03/04ROCHE : Bagudu praises wife as Kebbi signs MoU on cancer services
AQ
03/04FDA grants Breakthrough Device Designation for Roche's Elecsys GALAD score to..
GL
03/03ROCHE : FDA grants Breakthrough Therapy Designation for Roche's Esbriet (pirfeni..
PU
03/03ROCHE : FDA Grants Breakthrough Therapy Designation for Genentech's Esbriet (pir..
BU
02/28Dicerna Announces Fourth Quarter and Full Year 2019 Financial Results and Pro..
AQ
02/26ROCHE : Chemical reactions database updates to improve R&D information exchange
AQ
02/26BICYCLE THERAPEUTICS : Announces Exclusive Strategic Collaboration with Genentec..
AQ
02/26HALOZYME THERAPEUTICS : Announces FDA Has Accepted Biologics License Application..
AQ
02/25ROCHE : FDA Accepts Genentech's Biologics License Application for Fixed-dose Sub..
BU
02/25FDA accepts Roche's Biologics License Application for fixed-dose subcutaneous..
GL
02/24CHUGAI PHARMACEUTICAL : Obtains Approval for Additional Indication of Alecensa f..
AQ
02/24CHUGAI PHARMACEUTICAL CO. LTD. : - Anti-CD20 Monoclonal Antibody 'Rituxan,' Appr..
AQ
02/24CHUGAI PHARMACEUTICAL : Obtains Approval for Additional Indication of Rozlytrek ..
AQ
02/19ROCHE : FDA Grants Priority Review to Genentech's Tecentriq Monotherapy as First..
BU
02/19FDA grants priority review to Roche's Tecentriq monotherapy as first-line tre..
GL
02/17Chugai Pharmaceutical Co., Ltd. - Changes to Marketing Arrangements of the SG..
AQ
02/17CHUGAI PHARMACEUTICAL : Files for Additional Indications of Tecentriq and Avasti..
AQ
02/17ROCHE : China National Medical Products Administration grants approval of Roche'..
AQ
02/14CHUGAI PHARMACEUTICAL : Foundation Medicine and Chugai Announce Partnership with..
AQ
02/14CHUGAI PHARMACEUTICAL : Polatuzumab Vedotin Achieved Primary Endpoint in the Jap..
AQ
02/14Sosei Heptares Operational Highlights and Consolidated Results for the 12 Mon..
AQ
02/14China National Medical Products Administration grants approval of Roche's Tec..
GL
02/13CHUGAI PHARMACEUTICAL : Wins Second Prize for the Second Consecutive Year in the..
AQ
02/13CHUGAI PHARMACEUTICAL : Joins the Consortium of Companies Promoting Anti-Smoking..
AQ
02/11ELI LILLY AND : Lilly Announces Topline Results for Solanezumab from the Dominan..
AQ
02/11ROCHE : Genentech Provides Topline Results From Investigator-Led Phase II/III Tr..
AQ
02/11REMINDER : Invitation to Roche's Virtual Early Drug Development gRED Event 2020
PU
02/10CHUGAI PHARMACEUTICAL : Supports National Cancer Center Japan for an Investigato..
AQ
02/10CHUGAI PHARMACEUTICAL CO. LTD. : - Support for Control of Novel Coronavirus
AQ
02/10GENENTECH : Provides Topline Results From Investigator-Led Phase II/III Trial Wi..
BU
02/10Roche provides topline results from investigator-led Phase II/III trial with ..
GL
02/07ROCHE : to present new data on Tecentriq in combination with Avastin that shows ..
PU
02/06GENENTECH : 's Risdiplam Showed Significant Improvement in Motor Function in Peo..
BU
02/06Roche's risdiplam showed significant improvement in motor function in people ..
GL
02/05CHUGAI PHARMACEUTICAL : Supports Statement of Japan Climate Initiative and Recom..
AQ
01/31CHUGAI PHARMACEUTICAL : Organizational and Personnel Changes
AQ
01/31CHUGAI PHARMACEUTICAL : Notice of Distribution of Retained Earnings
AQ
01/31ROCHE : Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces Financi..
AQ
01/31CHUGAI PHARMACEUTICAL : Announces 2019 Full Year Results and Forecasts for 2020
AQ
01/31CHUGAI PHARMACEUTICAL : Notice Regarding the Difference of Individual Financial ..
AQ
01/31ROCHE : announces CHMP recommendation for EU approval of Venclyxto plus Gazyvaro..
PU
01/31GILEAD SCIENCES : Sandra Horning, MD, Joins Gilead Sciences' Board of Directors
AQ
01/31REMINDER : Invitation to Roche's live audio webcast on efficacy and safety of ri..
PU
01/30ROCHE : Full-year 2019 Investor Update
PU
01/30ROCHE : Full-Year 2019 Presentation
PU
01/30Roche reports very strong results in 2019
GL
01/29CHUGAI PHARMACEUTICAL : Notice Concerning Execution of Settlement Agreement on A..
AQ
01/27ROCHE : Genentech Provides an Update on Phase III Study of Tecentriq in People W..
AQ
01/27ROCHE : Invitation to Roche's Virtual Early Drug Development gRED Event 2020
PU
01/27GENENTECH : Submits Supplemental Biologics License Application to the FDA for Te..
BU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ROCHE HOLDING AG